Connect with us

HEALTH

REVEALED: How to treat diabetes, back pain, others with pineapple leaves

Published

on

WAIST PAIN REMEDY

Pineapple leaves can do wonders to your health, and before you ponder further go and grab some boiled water of pineapple leaves to stay fit and healthy

PINEAPPLE LEAVES: Do not waste it any more, why complain of inflammatory pains and waist pain, make tea from it. It wipes all pains in seconds, heals ulcer and cough too. It nourishes the body and it is better than poisoning your system with ibrufen capsules, tramadol pain reliever that do endanger life and cause ulcer…
Just boil and drink.

Pineapple Leaves contains
👉Calcium oxalate
👉Bromelin enzyme
👉Pectic substantial
👉Fiber
👉Cellulose
👉Pentose

HEALS BLEEDING FROM NOSE
For those of you who experience frequent bleeding from nose because of fatigue or stress, you can cure it by drinking boiled water pineapple leaves regularly. To make it a bit tastier, you can add some honey to it.

DRIVES AWAY WEAKNESS
Pineapple leaves are also effective in curing weaknesses by providing energy and increasing blood circulation.

BOOSTS IMMUNITY
Pineapple leaves are also significant in boosting the immunity of our body by helping it fighting against disease causing microorganisms such as viruses, fungi, bacteria and so on.

CONTROLS DIABETES
Pineapple, being rich in fiber, is a great food for diabetics and intake of pineapple leaves results in improved blood sugar, insulin, and lipid levels.

GidiNews is exclusively designed to cover and report Lagos, Nigeria's commercial capital city. We bring you news updates, reports, opinions and analyses in Politics, Business, Sports, Entertainment, Crime, Health and Education among others. GOT NEWS FOR US? Reach us: +2349090870065, +2348055441309

HEALTH

Court dismisses suit challenging Lagos Okada ban

Published

on

By

The Federal High Court sitting in Lagos, has dismissed a suit by a Lagos resident challenging the Lagos State Government’s restriction of commercial motorcycles from some of its roads.

Justice Akintayo Aluko held that the applicant, Julius Ajibulu, “failed woefully” in his bid to reverse the ban which has been in place since 2018.

The judge held that Ajibulu also failed, among others, to establish that the Lagos State government has no power to ban the operation of tricycles and motorcycles in respect of the designated roads in the state.

The judgment followed the Plaintiff’s suit marked FHC/L/CS/1389/2020 against the Governor of Lagos State, Attorney General of Lagos State, Commissioner for Transportation and Speaker, Lagos State House of Assembly as 1st to fourth defendants respectively.

Lagos State had on Monday January 27, 2020 moved against commercial motorcycles (Okada) and tricycles (Keke NAPEP), proscribing their operations in six Local Government Areas (LGAs), nine Local Council Development Areas (LCDAs) and 10 major highways across the state with effect from February 1, 2020.

The government directed security operatives to embark on a total enforcement of the State’s Transport Sector Reform Law of 2018 to immediately address the chaos and disorderliness created by illegal operations of Okada and tricycle riders in restricted areas.

The government also banned Okada and tricycles from plying 40 bridges and flyovers across the State.

But Ajibulu contended that sections 15, 16, 19, 46 and 68 of the Lagos State Transport Sector Reform Law 2018, violated sections 1,4,5, items 11 and 63 of the exclusive legislative list in part 1, second schedule to the constitution.

He argued that it also offended section 10(3)(t) of the Federal Road Safety Commission (Establishment) Act, section 92 of the Federal Road Safety Commission (Establishment) Act, and section 1 of the Federal Highways Act/Subsidiary Legislation Cap F13, LFN, 2004.

In his judgment delivered on January 12, 2023, a copy of which was obtained by The Nation yesterday, the judge agreed with the defendants that Ajibulu’s case did not hold water.

Justice Aluko agreed, as Ajibulu argued, that section 4(3) of the Constitution gives the National Assembly power to make laws with respect to any matter in the exclusive legislative list to the exclusion of the Houses of Assembly of States.

He held: “The Plaintiff has referred the court to items 11 and 63 of part 1 in the exclusive legislative list which have to do with construction, alteration and maintenance of such roads as may be declared by the National Assembly to be Federal trunk roads and traffic on Federal trunks roads.

“The Plaintiff has however failed to show to the court that all the over 40 roads and bridges listed in his reliefs are Federal trunk roads declared by the National Assembly as provided under items 11 and 63 in the Exclusive Legislative list under part 1 of the 2nd schedule to the Constitution.

“The Plaintiff failed to establish before the court that the provisions of sections 15, 16, 19, 46 and 68 of the Lagos State Transport Sector Reform Law 2018 were made to apply to the operations of tricycles and motorcycles in respect of the over 40 roads mentioned in his reliefs.”

The judge noted that Ajibulu “failed woefully to prove his entitlement to the reliefs stated in the originating summons.

“The Plaintiffs has failed to establish that the State House of Assembly has no power to have made the law in contention and has equally failed to establish that the State government has no power to ban the operation of tricycles and motorcycles in respect of the designated roads in Lagos State.

“Granting the reliefs of the Plaintiff without placing any credible evidence before the court is tantamount to preventing the State House of Assembly from making laws for the peace, order and good government of the state or any part thereof and engaging in such venture will undoubtedly constitute a violation of and amount to overrunning section 4(7)CFRN, 1999 (as amended).

The Plaintiff failed to establish before the court that the provisions of sections 15, 16, 19, 46 and 68 of the Lagos State Transport Sector Reform Law 2018 were made to apply to the operations of tricycles and motorcycles

“That is forbidden and this court will not venture into such unconstitutional enterprise.

“Coming from the foregoing, the Plaintiff has failed to prove his case by credible evidence as required by law. Accordingly, the case of the Plaintiff lacks merit and same is hereby dismissed.”

Continue Reading

HEALTH

“Nigeria to increase effort in fighting sub-standard products”

Published

on

By

By Michael Dibie

Minister of state for Health, Joseph Ekumankama has reiterated that the government of Nigeria will continue to fight the activities of sub-standard products in the health sector which has over the years impeded operations in the industry. The minister made the promise at the West African Postgraduate College of Pharmacists (WAPCP)/ The National Institute for Pharmaceutical Research and Development (NIPRD) scientific workshop held in Abuja.

According to the minister, the government will increase its effort in fighting the menace through the activities of the National Agency for Food and Drug Administration (NAFDAC) and Standard Organisation of Nigeria (SON),

“Sub-standard product has been a fight we have been fighting for years and we will continue to do so, it may not stop today but we will support the agency to continue to fight it, he said”

Speaking on the workshop, he notated that auspicious event is aimed at bringing together critical stakeholders within the pharmaceutical sector to review the existing capacities for the local production of API in Nigeria and develop strategies to accelerate the process in the West African Region, leveraging on the African Free Continental Trade Area (AfCFTA).

According to the minister, there are still significant barriers to access to quality medicines and healthcare provision to the Nigeria population.

“The situation where there is no single pharmaceutical company that produces any APIs or pharmaceutical excipients locally is no longer tolerable. All of the APIs used by the industries in Nigeria are imported from India, China, the USA and Germany, he added”

In a keynote address, the Director General (NIPRD), Dr. Obi Peter Adigwe said that NIPRD has proffered solutions both national and international willing to bring in innovations that can help Africa and taking Nigeria projects to the next level.

“We train people in the area of traditional medicines through harnessing local ingredients and creating jobs. Our multi-billion Laboratory is almost completed and new innovations in the health sector are being looked into in other to access new ways or avenues of doing things, he added’
He also noted that NIPRD will continue to focus on innovative projects for the people that will encourage job creation and access to quality health delivery

President of the West African Postgraduate College of Pharmacists, Prof. Cecilia Igwilo called on developed countries to support the sector in getting all the active ingredients from the research table into the pilot table to production. She urged the agencies to partner for developmental research projects.

‘If we have active ingredients, we want to push 1-3, we must make sure that we patted that through the proper organization so that it will be there for the next 10 years depending on the duration in other to recover and ensure that no other person does what we are doing, she said”

Speaking on the effect of the Covid-19 on Africa, Chief of Party, USP, MOPA ESUGA said. The African continent was worst hit by scarcity of essential medication and needed medical supplies on account of export bans placed by India and China.

According to him, the manufacture of APIs is still at a modest level in Sub-Saharan Africa and South Africa taking the lead.
“I believe my role today is not just about the science of API manufacturing but agenda-setting that should galvanize the key stakeholders towards strategies that make for the manufacture of APIs in the West Africa sub-region”

It should be noted that in sub-Saharan Africa (SSA), where the overall pharmaceutical market size is worth US$ 20 billion annually, the production of life-saving medicines is furthermore concentrated in very few countries: 50 per cent of pharmaceutical manufacturing takes place in South Africa and an additional 40 per cent in Nigeria, Ghana, Kenya and Uganda combined.

The overall African Pharmaceutical sector is worth US$ 30 billion per annum. However, the pharmaceutical manufacturing sector in Africa contributes to only 25-30 per cent of the continent’s needs.

NIPRD is a Federal Government Parastatal under the Federal Ministry of Health. The institute was designated a center of Excellence in the African sub-region in research and development of drugs and vaccines, phytomedicines, and diagnostic towards improving the health and well-being of Nigerians and mankind.

Continue Reading

HEALTH

“This is why you may have contacted Omicron without knowing” -WHO

Published

on

The Omicron COVID-19 variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organisation said Sunday.

The Delta variant, first identified in India earlier this year, is responsible for most of the world’s coronavirus infections.

But South Africa’s discovery of Omicron – which has a large number of mutations — last month prompted countries around the world to impose travel bans on southern African countries and reintroduce domestic restrictions to slow its spread.

The WHO said Omicron had spread to 63 countries as of December 9. 

The faster transmission was noted in South Africa, where Delta is less prevalent, and in Britain, where Delta is the dominant strain.

But it stressed that a lack of data meant it could not say if Omicron’s rate of transmission was because it was less prone to immune responses, higher transmissibility, or a combination of both.

Early evidence suggests Omicron causes “a reduction in vaccine efficacy against infection and transmission”, the WHO said in a technical brief.

“Given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs,” it added.

Omicron infections have so far caused “mild” illness or asymptomatic cases, but the WHO said the data was insufficient to establish the variant’s clinical severity.

South Africa reported Omicron to the WHO on November 24. Vaccine manufacturers Pfizer/BioNTech last week said three doses of their jabs were still effective against Omicron.

Countries with sufficient vaccine supplies such as Britain and France have encouraged their populations to receive a third “booster” jab to fight Omicron.

(AFP) 

Continue Reading

Most Read